Publicaciones en 2025
Moreno-Montilla MT, Pedraza-Arevalo S, Martínez-López A, Blázquez-Encinas R, García-Vioque V, Rodríguez-Ortiz L, Valenzuela-Molina F, Rufián-Andújar B, Granados-Rodríguez M, Ortega-Salas R, Alors-Pérez E, Vázquez-Borrego MC, Romero-Ruiz A, Castaño JP, Arjona-Sánchez A, Ibáñez-Costa A. Exploring RNA biology in pseudomyxoma peritonei uncovers splicing dysregulation as a novel, targetable molecular vulnerability. CANCER GENE THERAPY. 2025. 721-736. DOI:10.1038/s41417-025-00911-x. IF: 5 Q1 D2
Mantrana A, Sánchez-Montero MT, Navarrete-Sirvent C, Herrera-Casanova N, Mena-Osuna R, Rivas-Crespo A, Díaz-Chacon A, Avila-Oca V, Toledano-Fonesca M, García-Ortíz MV, González-Fernández R, Gomez-España MA, Villar C, Medina-Fernádez FJ, Aranda E, Guil-Luna S, Rodríquez-Ariza A. Glycolysis Inhibition Restores Immune Sensitivity in GSNOR-Deficient Colorectal Cancer. LABORATORY INVESTIGATION. 2025. -. DOI:10.1016/j.labinv.2025.104250. IF: 4,2 Q1 D2
Fuentes-Fayos AC, G-García ME, Sánchez-Medianero T, Apps J, Flores-Martínez A, De la Rosa-Herencia AS, Gil-Duque I, Otto G, Venegas-Moreno E, Ruiz-Valdepeñas EC, Herrera-Martínez AD, Solivera J, Gahete MD, Cano DA, Ortega R, Soto-Moreno A, Gálvez-Moreno MA, Martínez-Barberá JP, Luque RM. Impaired splicing machinery in craniopharyngiomas unveils PRPF8 and RAVER1 as novel biomarkers and therapeutic targets. ACTA NEUROPATHOLOGICA COMMUNICATIONS. 2025. -. DOI:10.1186/s40478-025-02040-w. IF: 5,7 Q1 D2
Sánchez SG, Fernández JG, Cascales-Campos PA, Gil AG, Manzanedo I, Perez FP, Gómez DD, González-de Pedro C, Diaz EA, Sanchez DP, Prada-Villaverde A, Torrejimeno IJ, Lacueva J, Caravaca-García I, Torres-Melero J, Sanchez-Garcia S, Reques ED, Plaza CR, Gutierrez-Calvo A, Bayón LG, Morales-Soriano R, López-Mozos F, Bjelic L, Alvarez JG, Fernandez MEM, Santos ET, García AT, Seoane RA, Armas MA, Garaulet ET, Campos PV, Roda EB, Caro CR, Fadrique AG, Arjona-Sánchez A. Interval Cytoreductive Surgery and Cisplatin- or Paclitaxel-Based HIPEC for Advanced Ovarian Cancer. JAMA NETWORK OPEN. 2025. -. DOI:10.1001/jamanetworkopen.2025.17676. IF: 9,7 Q1 D1
Cascales-Campos PA, Lacueva FJ, Carbonell-Morote S, Gonzalez-Gil A, Alcaraz-Solano A, Caravaca I, Aranaz V, Gómez-Dueñas G, Gil-Gómez E, Arjona-Sánchez A, Ramia JM. Intraperitoneal Intraoperative Chemotherapy in Advanced Ovarian Cancer: Rethinking the Future Beyond Complete Macroscopic Resection. ANNALS OF SURGICAL ONCOLOGY. 2025. 5616-5623. DOI:10.1245/s10434-025-17432-4. IF: 3,5 Q1 D2
Carbonell-Morote S, Arjona-Sanchez A, Cascales-Campos PA, Gonzalez-Gil A, Gomez-Duenas G, Gil-Gomez E, Caravaca-Garcia I, Aranaz V, Lacueva FJ, Ramia JM. Textbook outcome in ovarian cancer and its impact on survival: comparative study. WORLD JOURNAL OF SURGICAL ONCOLOGY. 2025. -. DOI:10.1186/s12957-025-03686-5. IF: 2,5 Q1 D3
Lozano RC, Giménez MB, Medina-Fernández J, Delgado FJB. What about the robotic approach in rectal cancer?. MINERVA SURGERY. 2025. 409-422. DOI:10.23736/S2724-5691.25.10861-7. IF: 0,9 Q3 D
Hamm JJM, van den Berg R, Andrinopoulou ER, Zwanenburg ES, Musters GD, Tanis PJ, Arjona-Sanchez A. Adjuvant hyperthermic intraperitoneal chemotherapy in patients with colon cancer at high risk of peritoneal metastases: individual patient data meta-analysis. BJS-BRITISH JOURNAL OF SURGERY. 2025. -. DOI:10.1093/bjs/znaf076. IF: 8,8 Q1 D1
Dorcaratto D, Garcés-Albir M, Palomares-Casasús S, Sánchez-Cabús S, Suárez-Artacho G, Jorba-Martín R, Blanco-Fernández G, Cugat-Andorra E, Ausania F, Fondevila-Campo C, Ramia-Angel JM, Sánchez-Hidalgo JM, Serrablo-Requejo A, Martín-Pérez E, De la Hoz-Rodríguez A, Muñoz-Forner E, Mora-Oliver I, Rodríguez-Blanco M, Cepeda-Franco C, Memba R, López-Guerra D, García-Domingo MI, Landi F, Sánchez-Velázquez P, Losa-Boñar N, Rodríguez-Laiz G, Paterna S, Serradilla-Martín M, Ielpo B, García-Romera A, Padillo-Ruiz J, Sabater-Ortí L. Blumgart Anastomosis Versus Invaginating Pancreatogastrostomy for Reconstruction after Pancreatoduodenectomy. ANNALS OF SURGERY. 2025. 699-708. DOI:10.1097/SLA.0000000000006873. IF: 6,5 Q1 D1
Bhatt A, Stepanyan A, Moran BJ, Chi D, Fotopoulou C, Baumgartner JM, Bakrin N, Deraco M, Ferron G, Kepenekian V, Kusamura S, Lavoue V, Al Niaimi A, Arjona-Sanchez A, Sehouli J, Sukumar V, Turaga K, Villeneuve L, Planchamp F, Gutiérrez IZ, Brennan DJ, Glehen O. Peritonectomy procedures for peritoneal surface malignancies: PSOGI-ESGO-ISSPP Lyon consensus. BJS-BRITISH JOURNAL OF SURGERY. 2025. -. DOI:10.1093/bjs/znaf112. IF: 8,8 Q1 D1
Bhatt A, Fotopoulou C, Moran BJ, Chi DN, Stepanyan A, Baumgartner JM, Bakrin N, Deraco M, Ferron G, Kepenekian V, Kusamura S, Lavoue V, Al Niami A, Arjona-Sanchez A, Sehouli J, Sukumar V, Turaga K, Villeneuve L, Planchamp F, Brennan DJ, Gutiérrez IZ, Glehen O. Peritonectomy to enhance adequate cytoreductive surgery in peritoneal surface malignancy: review of nomenclature and boundaries. BJS-BRITISH JOURNAL OF SURGERY. 2025. -. DOI:10.1093/bjs/znaf099. IF: 8,8 Q1 D1
Publicaciones en 2024
Calleja R, Medina-Fernández FJ, Bergillos-Giménez M, Durán M, Torres-Tordera E, Díaz-López C, Briceño J. A comprehensive evaluation of 80 consecutive robotic low anterior resections: impact of not mobilizing the splenic flexure alongside low-tie vascular ligation as a standardized technique. JOURNAL OF ROBOTIC SURGERY. 2024. DOI: 10.1007/s11701-024-01917-7. IF: 2,2 Q2 D4
Camara-Perez J, Jimena I, Rodriguez-Cano MA, Sanz-Zorrilla A, Osuna-Soto J, Sanchez-Ramirez I, Sanchez-Medianero T, Galvez-Medina MJ, Ortega-Salas R, Leiva-Cepas F. Acute and chronic mammary periprosthetic histological changes of the muscle. JPRAS OPEN. 2024. 265-275. DOI: 10.1016/j.jpra.2024.06.010. IF: 1,5 Q3 D
Alors-Pérez E, Pedraza-Arevalo S, Blázquez-Encinas R, García-Vioque V, Agraz-Doblas A, Yubero-Serrano EM, Sánchez-Frías ME, Serrano-Blanch R, Gálvez-Moreno MA, Gracia-Navarro F, Gahete MD, Arjona-Sánchez A, Luque RM, Ibáñez-Costa A, Castaño JP. Altered CELF4 splicing factor enhances pancreatic neuroendocrine tumors aggressiveness influencing mTOR and everolimus response. MOLECULAR THERAPY NUCLEIC ACIDS. 2024. DOI: 10.1016/j.omtn.2023.102090. IF: 6,5 Q1 D2
Romero-Ruiz A, Granados-Rodríguez M, Bura FI, Valenzuela-Molina F, Rufián-Andújar B, Martínez-López A, Rodríguez-Ortiz L, Ortega-Salas R, Torres-Martínez M, Moreno-Serrano A, Castaño J, Michán C, Alhama J, Vázquez-Borrego MC, Arjona-Sánchez A. Breaking the Mucin Barrier: A New Affinity Chromatography-Mass Spectrometry Approach to Unveil Potential Cell Markers and Pathways Altered in Pseudomyxoma Peritonei. BIOLOGICAL PROCEDURES ONLINE. 2024. DOI: 10.1186/s12575-024-00239-0. IF: 3,7 Q1 D3
Casares-Jimenez M, Garcia-Garcia T, Suárez-Cárdenas JM, Perez-Jimenez AB, Martín MA, Caballero-Gómez J, Michán C, Corona-Mata D, Risalde MA, Perez-Valero I, Guerra R, Garcia-Bocanegra I, Rivero A, Rivero-Juarez A, Garrido JJ. Correlation of hepatitis E and rat hepatitis E viruses urban wastewater monitoring and clinical cases. SCIENCE OF THE TOTAL ENVIRONMENT. 2024. DOI: 10.1016/j.scitotenv.2023.168203. IF: 8,2 Q1 D1
Trinidad-Gutiérrez I, Vázquez-Borrego MC, Aguilera-Fernández E, Velez-Castaño JE, Muriel-López CE, Rodríguez-Ortíz L, Gómez A, Berchez-Moreno F, Hervás C, Romero-Ruiz A, Arjona-Sánchez A. Efficacy of systemic Chemotherapy on high-risk stage II and III Mucnious colon cancer. CHEMUCCA study part I. EJSO. 2024. DOI: 10.1016/j.ejso.2024.108642. IF: 3,5 Q1 D2
Torres E, Pellegrino G, Granados-Rodríguez M, Fuentes-Fayos AC, Velasco I, Coutteau-Robles A, Legrand A, Shanabrough M, Perdices-Lopez C, Leon S, Yeo SH, Manchishi SM, Sánchez-Tapia MJ, Navarro VM, Pineda R, Roa J, Naftolin F, Argente J, Luque RM, Chowen JA, Horvath TL, Prevot V, Sharif A, Colledge WH, Tena-Sempere M, Romero-Ruiz A. Kisspeptin signaling in astrocytes modulates the reproductive axis. JOURNAL OF CLINICAL INVESTIGATION. 2024. DOI: 10.1172/JCI172908. IF: 13,3 Q1 D1
Manuel DM, Gonzalo GD, Lidia RO, Manuel SHJ, Antonio GS, Angela CA, Sebastián RP, Francisca VM, Blanca RA, Carmen VBM, Antonio RR, Javier BD, Alvaro AS. Laparoscopic versus open approach for interval cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) in advanced epithelial ovarian cancer: a matched comparative study. SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES. 2024. 66-74. DOI: 10.1007/s00464-023-10508-w. IF: 2,4 Q2 D3
Herruzo-Ruiz AM, Peralbo-Molina A, López CM, Michán C, Alhama J, Chicano-Gálvez E. Mass spectrometry imaging in environmental monitoring: From a scarce existing past to a promising future. TRENDS IN ENVIRONMENTAL ANALYTICAL CHEMISTRY. 2024. DOI: 10.1016/j.teac.2024.e00228. IF: 11,1 Q1 D1
Rufián-Andújar B, Medina-Fernández FJ, Bergillos-Jiménez M, Díaz-López CA, Briceño-Delgado FJ. Robotic and transvaginal excision of rectal leiomyoma - a video vignette. COLORECTAL DISEASE. 2024. 397-398. DOI: 10.1111/codi.16832. IF: 2,9 Q2 D5
Alors-Pérez E, Blázquez-Encinas R, Moreno-Montilla MT, García-Vioque V, Jiménez-Vacas JM, Mafficini A, González-Borja I, Luchini C, Sánchez-Hidalgo JM, Sánchez-Frías ME, Pedraza-Arevalo S, Romero-Ruiz A, Lawlor RT, Viúdez A, Gahete MD, Scarpa A, Arjona-Sánchez A, Luque RM, Ibáñez-Costa A, Castaño JP. Spliceosomic dysregulation in pancreatic cancer uncovers splicing factors PRPF8 and RBMX as novel candidate actionable targets. MOLECULAR ONCOLOGY. 2024. 2524-2540. DOI: 10.1002/1878-0261.13658. IF: 5 Q1 D3
Blázquez-Encinas R, Alors-Pérez E, Moreno-Montilla MT, García-Vioque V, Sánchez-Frias ME, Mafficini A, López-Cánovas JL, Bousquet C, Gahete MD, Lawlor RT, Luque RM, Scarpa A, Arjona-Sánchez A, Pedraza-Arevalo S, Ibáñez-Costa A, Castaño JP. The Exon Junction Complex component EIF4A3 plays a splicing-linked oncogenic role in pancreatic ductal adenocarcinoma. CANCER GENE THERAPY. 2024. 1646-1657. DOI: 10.1038/s41417-024-00814-3. IF: 4,8 Q1 D2
Alvaro-Sánchez E. Nursing care in the postoperative period after Glenn surgery. A case report. ENFERMERIA INTENSIVA. 2024. 146-158. DOI: 10.1016/j.enfi.2023.05.003. IF: 1,1 Q3 D
Campos PV, Vázquez-Borrego MC, Martínez-Quintanilla J, Cabot D, Romero-Ruíz A, Granados-Rodríguez M, Bura FI, García-Arranz M, García-Olmo D, Arjona-Sánchez A. Undetectable circulating tumor DNA confirms the inability of pseudomyxoma peritonei to systemic dissemination. EJSO. 2024. DOI: 10.1016/j.ejso.2024.108395. IF: 3,5 Q1 D2
Publicaciones en 2023
Arias-de la Rosa I, Ruiz-Ponce M, Cuesta-López L, Pérez-Sánchez C, Leiva-Cepas F, Gahete M, Navarro P, Ortega R, Cordoba J, Pérez-Pampin E, González A, Lucendo AJ, Collantes-Estévez E, López-Pedrera C, Escudero-Contreras A, Barbarroja N. Clinical features and immune mechanisms directly linked to the altered liver function in patients with rheumatoid arthritis. EUROPEAN JOURNAL OF INTERNAL MEDICINE. 2023. 49-58. DOI: 10.1016/j.ejim.2023.08.002. IF: 8 Q1 D2
Guil-Luna S, Rivas-Crespo A, Navarrete-Sirvent C, Mantrana A, Pera A, Mena-Osuna R, Toledano-Fonseca M, García-Ortíza MV, Villar C, Sanchez-Montero MT, Krueger J, Medina-Fernandez FJ, Haba-Rodríguez JDL, Auxiliadora E, Aranda E, Rudd CE, Rodríguez-Ariza A. Clinical significance of glycogen synthase kinase 3 (GSK-3) expression and tumor budding grade in colorectal cancer: Implications for targeted therapy. BIOMEDICINE & PHARMACOTHERAPY. 2023. DOI: 10.1016/j.biopha.2023.115592. IF: 7,5 Q1 D1
Rufian-Andujar B, Valenzuela-Molina F, Rodriguez-Ortiz L, Rufian-Pena S, Briceno-Delgado FJ, Arjona-Sanchez A. Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis from Urothelial Origin: a Case Report and Literature Review. INDIAN JOURNAL OF SURGICAL ONCOLOGY. 2023. 106-108. DOI: 10.1007/s13193-022-01616-5. IF: 0,5 Q4 D
Arjona-Sánchez A, Espinosa-Redondo E, Gutiérrez-Calvo A, Segura-Sampedro JJ, Pérez-Viejo E, Concepción-Martín V, Sánchez-García S, García-Fadrique A, Prieto-Nieto I, Barrios-Sanchez P, Torres-Melero J, Faraco MR, Prada-Villaverde A, Carrasco-Campos J, Artiles-Armas M, Villarejo-Campos P, Ortega-Pérez G, Boldo-Roda E, Sánchez-Hidalgo JM, Casado-Adam A, Rodríguez-Ortiz L, Aranda E, Cano-Osuna MT, Díaz-López C, Romero-Ruiz A, Briceño-Delgado J, Rufián-Peña S. Efficacy and Safety of Intraoperative Hyperthermic Intraperitoneal Chemotherapy for Locally Advanced Colon Cancer A Phase 3 Randomized Clinical Trial. JAMA SURGERY. 2023. 683-691. DOI: 10.1001/jamasurg.2023.0662. IF: 16,9 Q1 D1
Pontes-García A, Martínez-López A, Rodríguez-Ortiz L, Valenzuela-Molina F, Rufián-Andújar B, Sánchez-Hidalgo JM, Casado-Adam A, Gordon-Suarez A, Rufián-Peña S, Vázquez-Borrego MC, Romero-Ruiz A, Arjona-Sánchez A. Establishment of a desirable dose using neutral argon plasma to eradicate miliary peritoneal implants: A phase I/II controlled trial. EJSO. 2023. DOI: 10.1016/j.ejso.2023.07.004. IF: 3,8 Q1 D2
Arjona-Sanchez A, Martinez-López A, Moreno-Montilla MT, Mulsow J, Lozano-Lominchar P, Martínez-Torres B, Rau B, Canbay E, Sommariva A, Milione M, Deraco M, Sgarbura O, Torgunrud A, Kepenekian V, Carr NJ, Hoorens A, Delhorme JB, Wernert R, Goere D, Martin-Roman L, Cosyns S, Flatmark K, Davidson B, Khellaf L, Pereira-Perez F, Rodriguez-Ortiz L, Ibáñez-Costa A, Romero-Ruiz A. External multicentre validation of pseudomyxoma peritonei PSOGI-Ki67 classification. EJSO. 2023. 1481-1488. DOI: 10.1016/j.ejso.2023.03.206. IF: 3,8 Q1 D2
Rubio-Lopez JD, Duran-Martinez M, Moreno-Blazquez A, Rodriguez-Ortiz L, Rufian-Andujar B, Valenzuela-Molina F, Adam AC, Sanchez-Hidalgo JM, Rufian-Pena S, Romero-Ruiz A, Briceno-Delgado J, Arjona-Sanchez A. Intraoperative metabolic changes associated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. LANGENBECKS ARCHIVES OF SURGERY. 2023. DOI: 10.1007/s00423-023-02770-2. IF: 2,3 Q2 D5
Valenzuela-Molina F, Bura FI, Vazquez-Borrego MC, Granados-Rodriguez M, Rufian-Andujar B, Rufian-Pena S, Casado-Adam A, Sanchez-Hidalgo JM, Rodriguez-Ortiz L, Ortega-Salas R, Martinez-Lopez A, Michan C, Alhama J, Arjona-Sanchez A, Romero-Ruiz A. Intraoperative oxygen tension and redox homeostasis in Pseudomyxoma peritonei: A short case series. FRONTIERS IN ONCOLOGY. 2023. DOI: 10.3389/fonc.2023.1076500. IF: 4,7 Q2 D4
Duran-Martinez M, Gomez-Duenas G, Rodriguez-Ortiz L, Sanchez-Hidalgo JM, Suarez AG, Casado-Adam A, Rufian-Pena S, Andujar BR, Valenzuela-Molina F, Vazquez-Borrego MC, Romero-Ruiz A, Briceno-Delgado J, Arjona-Sanchez A. Learning curve for minimal invasive cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) procedures. LANGENBECKS ARCHIVES OF SURGERY. 2023. DOI: 10.1007/s00423-023-02882-9. IF: 2,3 Q2 D5
Mena-Osuna R, Mantrana A, Guil-Luna S, Sanchez-Montero MT, Navarrete-Sirvent C, Morales-Ruiz T, Rivas-Crespo A, Toledano-Fonseca M, Garcia-Ortiz MV, Garcia-Jurado G, Gomez-Espana MA, Gonzalez-Fernandez R, Villar C, Medina-Fernandez FJ, Villalba JM, Aranda E, Rodriguez-Ariza A. Metabolic shift underlies tumor progression and immune evasion in S-nitrosoglutathione reductase-deficient cancer. JOURNAL OF PATHOLOGY. 2023. 261-275. DOI: 10.1002/path.6080. IF: 7,3 Q1 D1
Fuentes-Fayos AC, G-Garcia ME, Perez-Gomez JM, Montero-Hidalgo AJ, Martin-Colom J, Doval-Rosa C, Blanco-Acevedo C, Torres E, Toledano-Delgado A, Sanchez-Sanchez R, Peralbo-Santaella E, Ortega-Salas RM, Jimenez-Vacas JM, Tena-Sempere M, Lopez M, Castano JP, Gahete MD, Solivera J, Luque RM. Metformin and simvastatin exert additive antitumour effects in glioblastoma via senescence-state: clinical and translational evidence. EBIOMEDICINE. 2023. DOI: 10.1016/j.ebiom.2023.104484. IF: 11,1 Q1 D1
Gómez-Dueñas G, Durán M, Calleja-Lozano R, Arjona-Sánchez A, Sánchez-Hidalgo JM, Rodríguez-Ortiza L, Ayllón-Terán MD, Campos-Hernández JP, Rodríguez-Benot A, Briceño J. Normothermic Regional Perfusion in Controlled Donation After Circulatory Determination of Death Simultaneous Pancreas - Kidney Transplantation. TRANSPLANTATION PROCEEDINGS. 2023. 2259-2261. DOI: 10.1016/j.transproceed.2023.09.007. IF: 0,9 Q4 D
Grávalos C, Pereira F, Vera R, Arjona-Sánchez A, Losa F, Ramos I, García-Alfonso P, Gonzalez-Bayón L, Cascales-Campos PA, Aranda E. Recommendations for the optimal management of peritoneal metastases in patients with colorectal cancer: a TTD and GECOP-SEOQ expert consensus statement. CLINICAL & TRANSLATIONAL ONCOLOGY. 2023. 3378-3394. DOI: 10.1007/s12094-023-03204-7. IF: 3,4 Q3 D
Pedraza-Arevalo S, Alors-Perez E, Blazquez-Encinas R, Herrera-Martinez AD, Jimenz-Vacas JM, Fuentes-Fayos AC, Reyes O, Ventura S, Sanchez-Sanchez R, Ortega-Salas R, Serrano-Blanch R, Galvez-Moreno MA, Gahete MD, Ibanez-Costa A, Luque RM, Castano JP. Spliceosomic dysregulation unveils NOVA1 as a candidate actionable therapeutic target in pancreatic neuroendocrine tumors. TRANSLATIONAL RESEARCH. 2023. 63-73. DOI: 10.1016/j.trsl.2022.07.005. IF: 7,8 Q1 D2
Lopez-Pedrera C, Patino-Trives AM, Cerdo T, Ortega-Castro R, Sanchez-Pareja I, Ibanez-Costa A, Munoz-Barrera L, Abalos-Aguilera MC, Ruiz-Vilchez D, Azpilcueta PS, Espinosa M, Barbarroja N, Escudero-Contreras A, Castano JP, Luque R, Ortega R, Aguirre MA, Perez-Sanchez C. Splicing machinery is profoundly altered in systemic lupus erythematosus and antiphospholipid syndrome and directly linked to key clinical features. JOURNAL OF AUTOIMMUNITY. 2023. DOI: 10.1016/j.jaut.2022.102990. IF: 12,8 Q1 D1
Jimenez-Vacas JM, Montero-Hidalgo AJ, Gomez-Gomez E, Saez-Martinez P, Fuentes-Fayos AC, Closa A, Gonzalez-Serrano T, Martinez-Lopez A, Sanchez-Sanchez R, Lopez-Casas PP, Sarmento-Cabral A, Olmos D, Eyras E, Castano JP, Gahete MD, Luque RM. Tumor suppressor role of RBM22 in prostate cancer acting as a dual-factor regulating alternative splicing and transcription of key oncogenic genes. TRANSLATIONAL RESEARCH. 2023. 68-79. DOI: 10.1016/j.trsl.2022.08.016. IF: 7,8 Q1 D2
Arjona-Sanchez A, Aziz O, Passot G, Salti G, Serrano A, Esquivel J, van der Speeten K, Sommariva A, Kazi M, Shariff U, Martinez-Regueira F, Piso P, Yonemura Y, Turaga K, Sgarbura O, Saklani AA, Tonello M, Rodriguez-Ortiz L, Vazquez-Borrego MC, Romero-Ruiz A. Laparoscopic cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: Long term oncologic outcomes from the international PSOGI registry. EJSO. 2023. DOI: 10.1016/j.ejso.2023.107001. IF: 3,8 Q1 D2
Llueca A, Ibanez MV, Cascales P, Gil-Moreno A, Bebia V, Ponce J, Fernandez S, Arjona-Sanchez A, Muruzabal JC, Veiga N, Diaz-Feijoo B, Celada C, Gilabert-Estelles J, Aghababyan C, Calero A, Lacueva J, Segura JJ, Maiocchi K, Llorca S, Villarin A, Climent MT, Delgado K, Serra A, Gomez-Quiles L, Llueca M. Neoadjuvant Chemotherapy plus Interval Cytoreductive Surgery with or without Hyperthermic Intraperitoneal Chemotherapy (NIHIPEC) in the Treatment of Advanced Ovarian Cancer: A Multicentric Propensity Score Study. CANCERS. 2023. DOI: 10.3390/cancers15174271. IF: 5,2 Q2 D3
Torun BC, Glehen O, Kepenekian V, Sardi A, Arjona-Sanchez A, Yonemura Y, Barat S, Morris D, Spiliotis J, Coccolini F, Sommariva A, Bartos A, Raza S, Vander Speteen K, Akin L, Irez T, Canbay E. Peritoneal metastasis of advanced epithelial ovarian carcinoma treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: A retrospective international multicentric data analysis. EJSO. 2023. 1489-1494. DOI: 10.1016/j.ejso.2023.03.214. IF: 3,8 Q1 D2
Cano-Valderrama O, Miguel TF, Bonito AC, Muriel JS, Fernandez FJM, Ros EP, Cabrera AMG, Cerdan-Santacruz C. Surgical treatment trends and outcomes for anal fistula: fistulotomy is still accurate and safe. Results from a nationwide observational study. TECHNIQUES IN COLOPROCTOLOGY. 2023. 909-919. DOI: 10.1007/s10151-023-02842-x. IF: 3,3 Q1 D3
PUBLICACIONES RECIENTES (2022-2023):
Arjona-Sanchez A. et al. Intraoperative hyperthermic intraperitoneal chemotherapy in locally advanced colon cancer (HIPECT4): a randomised, controlled, phase 3 trial. JAMA Surg 2023. Published online April 26, 2023. doi:10.1001/jamasurg.2023.0662
Duran-Martinez M., Arjona-Sanchez A. Learning Curve for Minimal Invasive Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Procedures. Langenbeck’s archives of Surgery. 2023 in press.
Arjona-Sánchez A, Martínez-López A, Moreno-Montilla MT, Mulsow J, Lozano-Lominchar P, Martínez-Torres B, Rau B, Canbay E, Sommariva A, Milione M, Deraco M, Sgarbura O, Torgunrud A, Kapenekian V, Carr NJ, Hoorens A, Delhorme JB, Wernert R, Goere D, Martin-Roman L, Cosyns S, Flatmark K, Davidson B, Khellaf L, Pereira-Perez F, Rodríguez-Ortiz L, Ibáñez-Costa A, Romero-Ruiz A; EuroPMP COST action and GECOP group (Rufián-Andújar B, Valenzuela-Molina F, Casado-Adam A, Sánchez-Hidalgo JM, Rufián-Peña S, Ortega-Salas R, Granados-Rodríguez M, Vázquez-Borrego MC, Bura FI, Castaño JP, Kusamura S, Baratti D, Guaglio M, Castaño PAA, Ruiz de Valbuena Bueno C, Quénet F, Yilmaz S, Canbay TB, Sola Vendrell E, González-Bayón L, Ceelen W, Willaert W, Demuytere J, Alberto-Vilchez ME, Gül-Klein S, Glehen O, Bonnefoy I, Odin C, Villeneuve L, Isaac S, Benzerdjeb N, Fontaine J, Bertheau P, Kassem M, Sourrouille I, Gelli M, Honore C, Dartigues P, Boige V, Verriele V, Brignad C, Averous G, Shields C, Aird J, Scapinello A, Biatta MC, Tonello M, Cenzi C. External multicentre validation of pseudomyxoma peritonei PSOGI-Ki67 classification. Eur J Surg Oncol. 2023. DOI: 10.1016/j.ejso.2023.03.206.
Rubio-López JD, Durán-Martínez M, Moreno-Blázquez A, Rodríguez-Ortiz L, Rufián-Andújar B, Valenzuela-Molina F, Casado-Adam A, Sánchez-Hidalgo JM, Rufián-Peña S, Romero-Ruiz A, Briceño-Delgado J, Arjona-Sánchez A. Intraoperative metabolic changes associated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Langenbecks Arck Surg. 2023. DOI: 10.1007/s00423-023-02770-2.
Valenzuela-Molina F, Bura FI, Vázquez-Borrego MC, Granados-Rodríguez M, Rufián-Andujar B, Rufián-Peña S, Casado-Adam A, Sánchez-Hidalgo JM, Rodríguez-Ortiz L, Ortega-Salas R, Martínez-López A, Michán C, Alhama J, Arjona-Sánchez A, Romero-Ruiz A. Intraoperative oxygen tension and redox homeostasis in Pseudomyxoma peritonei: A short case series. Front Oncol. 2023. DOI: 10.3389/fonc.2023.1076500.
Zwanenburg ES, Gehrels AM, Bastiaenen VP, Aalbers AGJ, Arjona-Sánchez A, Bellato V, van der Bilt JDW, D´Hoore ADD, Espinosa-Redondo E, Klaver CEL, Kusters M, Nagtegaal ID, van Ramshorst B, van Santvoort HC, Sica GS, Snaebjornsson P, Wasmann KATGM, de Wilt JHW, Wolthuis AM, Tanis PJ. Metachronous peritoneal metastases in patients with pT4b colon cancer: An international multicenter analysis of intraperitoneal versus retroperitoneal tumor invasion. Eur J Surg Oncol. 2022. DOI: 10.1016/j.ejso.2022.05.028.
Casado-Adam A, Rodríguez-Ortiz L, Rufián-Peña S, Muñoz-Casares C, Caro-Cuenca T, Ortega-Salas R, Fernández-Peralbo MA, Luque-de-Castro MD, Sánchez-Hidalgo JM, Hervás-Martínez C, Romero-Ruiz A, Briceño J, Arjona-Sánchez A. The role of intraperitoneal intraoperative chemotherapy with paclitaxel in the surgical treatment of peritoneal carcinomatosis from ovarian cancer-hyperthermica versus normothermia: A randomized controlled trial. J Clin Med. 2022. DOI: 10.3390/jcm11195785.
Durán-Martínez M, Calleja-Lozano R, Arjona-Sánchez A, Sánchez-Hidalgo JM, Ayllón-Terán MD, Rodríguez-Ortiz L, Campos-Hernández P, Rodríguez-Benot A, Briceño-Delgado J. Short- and Long-term intestinal complications after combined pancreas-kidney transplantation. Transplant Proc. 2022. DOI: 10.1016/j.transproceed.2022.09.014.
Rufián-Andujar B, Sánchez-Hidalgo JM, Rodríguez-Ortiz L, Arjona-Sánchez A, Rufián-Peña S, Briceño-Delgado FJ. Robotic right hemicolectomy for ileal neuroendocrine tumour. Colorectal Dis. 2022. DOI: 10.1111/codi.16138.
Pérez-de-Villar JM, Arjona-Sánchez A, Rufián-Andujar B, Valenzuela-Molina F, Sánchez-Hidalgo JM, Rodríguez-Ortiz L, Casado-Adam A, Viyuela-García C, Rufián-Peña S, Caro-Cuenca T, Moreno-Vega A, Briceño-Delgado J. Surgical treatment of vena cava leiomyosarcomas: Series of cases in a referral center and literatura review. Cir Esp (Engl Ed). 2022. DOI: 10.1016/j.cireng.2022.05.020.
Perdices-López C, Avendaño MS, Barroso A, Gaytán F, Ruiz-Pino F, Vázquez MJ, León S, Bhum Song Y, Sobrino V, Heras V, Romero-Ruiz A, Roa J, Mayor JR F, Murga C, Pinilla L, Kaiser UB, Tena-Sempere M. Connecting nutritional deprivation and pubertal inhibition via GRK2-mediated represión of kisspeptin actions in GnRH neurons. Metabolism. 2022. DOI: 10.1016/j.metabol.2022.155141.
Pereira F, Serrano A, Manzanedo I, Pérez-Viejo E, González-Moreno S, González-Bayón L, Arjona-Sánchez A, Torres J, Ramos I, Barrios ME, Cascales P, Morales R, Boldó E, García-Fadrique A, Artega X, Gutierrez-Calvo A, Sánchez-García S, Asensio E, Ramírez CP, Artiles M, Vaqué J, Parra PA, Villarejo P, Muñoz-Casares C, Turienzo E, Calero A, Jaén-Torrejimeno I, Prieto I, Galindo J, Borrego V, Marcello ME, Rihuete C, Carrasco J, Gómez-Quiles L. GECOP-MMC: phase IV randomized clinical trial to evaluate the efficacy of hyperthermic intraperitoneal chemotherape (HIPEC) with mytomicin-C after complete surgical cytoreduction in patients with colon cancer peritoneal metastases. BMC Cancer. 2022. DOI: 10.1186/s12885-022-09572-7.
Arjona-Sánchez A, Martínez-López A, Valenzuela-Molina F, Rufián-Andujar B, Rodríguez-Ortiz L, Granados-Rodríguez M, Romero-Ruiz A. ASO Author Reflections: Towards a Precision Medicine in Pseudomyxoma Peritonei. Ann Surg Oncol. 2022. DOI: 10.1245/s10434-021-10435-x.
Pedraza-Arevalo S, Ibáñez-Costa A, Blázquez-Encinas R, Branco MR, Vázquez-Borrego MC, Herrera-Martínez AD, Venegas-Moreno E, Serrano-Blanch R, Arjona-Sánchez A, Gálvez-Moreno MA, Korbonits M, Soto-Moreno A, Gahete MD, Charalambous M, Luque RM, Castaño JP. Epigenetic and post-transcriptional regulation of somatostatin receptor subtype 5 (SST5) in pituitary and pancreatic neuroendocrine tumors. Mol Oncol. 2022. DOI: 10.1002/1878-0261.13107.
Arjona-Sánchez A, Martínez-López A, Valenzuela-Molina F, Rufián-Andujar B, Rufián-Peña S, Casado-Adam A, Sánchez-Hidalgo JM, Rodríguez-Ortiz L, Medina-Fernández FJ, Díaz-López C, Granados-Rodriguez M, Ortega-Salas R, Castaño JP, Tena-Sempere M, Briceño-Delgado J, Romero-Ruiz A. A Proposal for Modification of the PSOGI Classification According to the Ki-67 Proliferation Index in Pseudomyxoma Peritonei. Ann Surg Oncol. 2022. DOI: 10.1245/s10434-021-10372-9.
Publicaciones 2023
Arjona-Sanchez A. et al. Intraoperative hyperthermic intraperitoneal chemotherapy in locally advanced colon cancer (HIPECT4): a randomised, controlled, phase 3 trial. JAMA Surg 2023. Published online April 26, 2023. doi:10.1001/jamasurg.2023.0662
Duran-Martinez M., Arjona-Sanchez A. Learning Curve for Minimal Invasive Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Procedures. Langenbeck’s archives of Surgery. 2023 in press.
Arjona-Sánchez A, Martínez-López A, Moreno-Montilla MT, Mulsow J, Lozano-Lominchar P, Martínez-Torres B, Rau B, Canbay E, Sommariva A, Milione M, Deraco M, Sgarbura O, Torgunrud A, Kapenekian V, Carr NJ, Hoorens A, Delhorme JB, Wernert R, Goere D, Martin-Roman L, Cosyns S, Flatmark K, Davidson B, Khellaf L, Pereira-Perez F, Rodríguez-Ortiz L, Ibáñez-Costa A, Romero-Ruiz A; EuroPMP COST action and GECOP group (Rufián-Andújar B, Valenzuela-Molina F, Casado-Adam A, Sánchez-Hidalgo JM, Rufián-Peña S, Ortega-Salas R, Granados-Rodríguez M, Vázquez-Borrego MC, Bura FI, Castaño JP, Kusamura S, Baratti D, Guaglio M, Castaño PAA, Ruiz de Valbuena Bueno C, Quénet F, Yilmaz S, Canbay TB, Sola Vendrell E, González-Bayón L, Ceelen W, Willaert W, Demuytere J, Alberto-Vilchez ME, Gül-Klein S, Glehen O, Bonnefoy I, Odin C, Villeneuve L, Isaac S, Benzerdjeb N, Fontaine J, Bertheau P, Kassem M, Sourrouille I, Gelli M, Honore C, Dartigues P, Boige V, Verriele V, Brignad C, Averous G, Shields C, Aird J, Scapinello A, Biatta MC, Tonello M, Cenzi C. External multicentre validation of pseudomyxoma peritonei PSOGI-Ki67 classification. Eur J Surg Oncol. 2023. DOI: 10.1016/j.ejso.2023.03.206.
Rubio-López JD, Durán-Martínez M, Moreno-Blázquez A, Rodríguez-Ortiz L, Rufián-Andújar B, Valenzuela-Molina F, Casado-Adam A, Sánchez-Hidalgo JM, Rufián-Peña S, Romero-Ruiz A, Briceño-Delgado J, Arjona-Sánchez A. Intraoperative metabolic changes associated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Langenbecks Arck Surg. 2023. DOI: 10.1007/s00423-023-02770-2.
Valenzuela-Molina F, Bura FI, Vázquez-Borrego MC, Granados-Rodríguez M, Rufián-Andujar B, Rufián-Peña S, Casado-Adam A, Sánchez-Hidalgo JM, Rodríguez-Ortiz L, Ortega-Salas R, Martínez-López A, Michán C, Alhama J, Arjona-Sánchez A, Romero-Ruiz A. Intraoperative oxygen tension and redox homeostasis in Pseudomyxoma peritonei: A short case series. Front Oncol. 2023. DOI: 10.3389/fonc.2023.1076500.
Publicaciones 2022
Zwanenburg ES, Gehrels AM, Bastiaenen VP, Aalbers AGJ, Arjona-Sánchez A, Bellato V, van der Bilt JDW, D´Hoore ADD, Espinosa-Redondo E, Klaver CEL, Kusters M, Nagtegaal ID, van Ramshorst B, van Santvoort HC, Sica GS, Snaebjornsson P, Wasmann KATGM, de Wilt JHW, Wolthuis AM, Tanis PJ. Metachronous peritoneal metastases in patients with pT4b colon cancer: An international multicenter analysis of intraperitoneal versus retroperitoneal tumor invasion. Eur J Surg Oncol. 2022. DOI: 10.1016/j.ejso.2022.05.028.
Casado-Adam A, Rodríguez-Ortiz L, Rufián-Peña S, Muñoz-Casares C, Caro-Cuenca T, Ortega-Salas R, Fernández-Peralbo MA, Luque-de-Castro MD, Sánchez-Hidalgo JM, Hervás-Martínez C, Romero-Ruiz A, Briceño J, Arjona-Sánchez A. The role of intraperitoneal intraoperative chemotherapy with paclitaxel in the surgical treatment of peritoneal carcinomatosis from ovarian cancer-hyperthermica versus normothermia: A randomized controlled trial. J Clin Med. 2022. DOI: 10.3390/jcm11195785.
Durán-Martínez M, Calleja-Lozano R, Arjona-Sánchez A, Sánchez-Hidalgo JM, Ayllón-Terán MD, Rodríguez-Ortiz L, Campos-Hernández P, Rodríguez-Benot A, Briceño-Delgado J. Short- and Long-term intestinal complications after combined pancreas-kidney transplantation. Transplant Proc. 2022. DOI: 10.1016/j.transproceed.2022.09.014.
Rufián-Andujar B, Sánchez-Hidalgo JM, Rodríguez-Ortiz L, Arjona-Sánchez A, Rufián-Peña S, Briceño-Delgado FJ. Robotic right hemicolectomy for ileal neuroendocrine tumour. Colorectal Dis. 2022. DOI: 10.1111/codi.16138.
Pérez-de-Villar JM, Arjona-Sánchez A, Rufián-Andujar B, Valenzuela-Molina F, Sánchez-Hidalgo JM, Rodríguez-Ortiz L, Casado-Adam A, Viyuela-García C, Rufián-Peña S, Caro-Cuenca T, Moreno-Vega A, Briceño-Delgado J. Surgical treatment of vena cava leiomyosarcomas: Series of cases in a referral center and literatura review. Cir Esp (Engl Ed). 2022. DOI: 10.1016/j.cireng.2022.05.020.
Perdices-López C, Avendaño MS, Barroso A, Gaytán F, Ruiz-Pino F, Vázquez MJ, León S, Bhum Song Y, Sobrino V, Heras V, Romero-Ruiz A, Roa J, Mayor JR F, Murga C, Pinilla L, Kaiser UB, Tena-Sempere M. Connecting nutritional deprivation and pubertal inhibition via GRK2-mediated represión of kisspeptin actions in GnRH neurons. Metabolism. 2022. DOI: 10.1016/j.metabol.2022.155141.
Pereira F, Serrano A, Manzanedo I, Pérez-Viejo E, González-Moreno S, González-Bayón L, Arjona-Sánchez A, Torres J, Ramos I, Barrios ME, Cascales P, Morales R, Boldó E, García-Fadrique A, Artega X, Gutierrez-Calvo A, Sánchez-García S, Asensio E, Ramírez CP, Artiles M, Vaqué J, Parra PA, Villarejo P, Muñoz-Casares C, Turienzo E, Calero A, Jaén-Torrejimeno I, Prieto I, Galindo J, Borrego V, Marcello ME, Rihuete C, Carrasco J, Gómez-Quiles L. GECOP-MMC: phase IV randomized clinical trial to evaluate the efficacy of hyperthermic intraperitoneal chemotherape (HIPEC) with mytomicin-C after complete surgical cytoreduction in patients with colon cancer peritoneal metastases. BMC Cancer. 2022. DOI: 10.1186/s12885-022-09572-7.
Arjona-Sánchez A, Martínez-López A, Valenzuela-Molina F, Rufián-Andujar B, Rodríguez-Ortiz L, Granados-Rodríguez M, Romero-Ruiz A. ASO Author Reflections: Towards a Precision Medicine in Pseudomyxoma Peritonei. Ann Surg Oncol. 2022. DOI: 10.1245/s10434-021-10435-x.
Pedraza-Arevalo S, Ibáñez-Costa A, Blázquez-Encinas R, Branco MR, Vázquez-Borrego MC, Herrera-Martínez AD, Venegas-Moreno E, Serrano-Blanch R, Arjona-Sánchez A, Gálvez-Moreno MA, Korbonits M, Soto-Moreno A, Gahete MD, Charalambous M, Luque RM, Castaño JP. Epigenetic and post-transcriptional regulation of somatostatin receptor subtype 5 (SST5) in pituitary and pancreatic neuroendocrine tumors. Mol Oncol. 2022. DOI: 10.1002/1878-0261.13107.
Arjona-Sánchez A, Martínez-López A, Valenzuela-Molina F, Rufián-Andujar B, Rufián-Peña S, Casado-Adam A, Sánchez-Hidalgo JM, Rodríguez-Ortiz L, Medina-Fernández FJ, Díaz-López C, Granados-Rodriguez M, Ortega-Salas R, Castaño JP, Tena-Sempere M, Briceño-Delgado J, Romero-Ruiz A. A Proposal for Modification of the PSOGI Classification According to the Ki-67 Proliferation Index in Pseudomyxoma Peritonei. Ann Surg Oncol. 2022. DOI: 10.1245/s10434-021-10372-9.
Publicaciones 2021
Rufian-Andujar B, Valenzuela-Molina F, Rufian-Pena S, Casado-Adam A, Sanchez-Hidalgo JM, Rodriguez-Ortiz L, Medina-Fernandez FJ, Diaz-Lopez C, Ortega-Salas R, Martinez-Lopez A, Briceno-Delgado J, Romero-Ruiz A, Arjona-Sanchez A. From the Ronnett to the PSOGI Classification System for Pseudomyxoma Peritonei: A Validation Study. ANNALS OF SURGICAL ONCOLOGY. 202 28(5):2819-2827. DOI: 10.1245/s10434-020-09560-w. IF: 5,344 Q1 D1
Rodriguez-Ortiz L, Arjona-Sanchez A, Ibanez-Rubio M, Sanchez-Hidalgo J, Casado-Adam A, Rufian-Pena S, Briceno-Delgado J. Laparoscopic cytoreductive surgery and HIPEC: a comparative matched analysis. SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES. 2021. 35(4):1778-1785. DOI: 10.1007/s00464-020-07572-x.
IF: 4,584 Q1 D2
Arjona-Sanchez A, Aziz O, Passot G, Salti G, Esquivel J, Van der Speeten K, Piso P, Nedelcut DS, Sommariva A, Yonemura Y, Turaga K, Selvasekar CR, Rodriguez-Ortiz L, Sanchez-Hidalgo JM, Casado-Adam A, Rufian-Pena S, Briceno J, Glehen O. Laparoscopic cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for limited peritoneal metastasis. The PSOGI international collaborative registry. EJSO. 2021. 47(6):1420-1426. DOI: 10.1016/j.ejso.2020.11.140.
IF: 4,424 Q1 D2
Romero-Ruiz A, Pineda B, Ovelleiro D, Perdices-Lopez C, Torres E, Vazquez MJ, Guler I, Jimenez A, Pineda R, Persano M, Romero-Baldonado C, Arjona JE, Lorente J, Munoz C, Paz E, Garcia-Maceira FI, Arjona-Sanchez A, Tena-Sempere M. Molecular diagnosis of polycystic ovary syndrome in obese and non-obese women by targeted plasma miRNA profiling. EUROPEAN JOURNAL OF ENDOCRINOLOGY. 2021. 185(5):637-652. DOI: 10.1530/EJE-21-0552.
IF: 6,664 Q1 D2
Rebollo-Roman A, Alhambra-Exposito MR, Herrera-Martinez Y, Leiva-Cepas F, Alzas C, Munoz-Jimenez C, Ortega-Salas R, Molina-Puertas MJ, Galvez-Moreno MA, Herrera-Martinez AD. Catecholaminergic Crisis After a Bleeding Complication of COVID-19 Infection: A Case Report. FRONTIERS IN ENDOCRINOLOGY. 202 12():-. DOI: 10.3389/fendo.202693004.
IF: 5,555 Q1 D3
Alors-Perez E, Blazquez-Encinas R, Alcala S, Viyuela-Garcia C, Pedraza-Arevalo S, Herrero-Aguayo V, Jimenez-Vacas JM, Mafficini A, Sanchez-Frias ME, Cano MT, Abollo-Jimenez F, Marin-Sanz JA, Cabezas-Sainz P, Lawlor RT, Luchini C, Sanchez L, Sanchez-Hidalgo JM, Ventura S, Martin-Hijano L, Gahete MD, Scarpa A, Arjona-Sanchez A, Ibanez-Costa A, Sainz B, Luque RM, Castano JP. Dysregulated splicing factor SF3B1 unveils a dual therapeutic vulnerability to target pancreatic cancer cells and cancer stem cells with an anti-splicing drug. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH. 2021. 40(1):-. DOI: 10.1186/s13046-021-02153-9.
IF: 11,161 Q1 D1
Gonzalez-Borja I, Alors-Perez E, Amat I, Alonso L, Viyuela-Garcia C, Goni S, Reyes JC, Ceballos-Chavez M, Hernandez-Garcia I, Sanchez-Frias ME, Santamaria E, Razquin S, Arjona-Sanchez A, Arrazubi V, Perez-Sanz J, Vera R, Fernandez-Irigoyen J, Castano JP, Viudez A. Deciphering CHFR Role in Pancreatic Ductal Adenocarcinoma. FRONTIERS IN MEDICINE. 2021. 8():-. DOI: 10.3389/fmed.2021.720128.
IF: 5,093 Q1 D2
4.- Bastiaenen VP, Aalbers AGJ, Arjona-Sánchez A, Bellato V, van der Bilt JDW, D'Hoore AD, Espinosa-Redondo E, Klaver CEL, Nagtegaal ID, van Ramshorst B, van Santvoort HC, Sica GS, Snaebjornsson P, Wasmann KATGM, de Wilt JHW, Wolthuis AM, Tanis PJ. Risk of metachronous peritoneal metastases in patients with pT4a versus pT4b colon cancer: An international multicentre cohort study. Eur J Surg Oncol. 2021 Sep;47(9):2405-2413. doi: 10.1016/j.ejso.2021.05.009. Q1 D2
Publicaciones 2020
Guil-Luna S, Mena R, Navarrete-Sirvent C, Lopez-Sanchez LM, Khouadri K, Toledano-Fonseca M, Mantrana A, Guler I, Villar C, Diaz C, Medina-Fernandez FJ, De la Haba-Rodriguez JR, Aranda E, Rodriguez-Ariza A,. Association of Tumor Budding With Immune Evasion Pathways in Primary Colorectal Cancer and Patient-Derived Xenografts. FRONTIERS IN MEDICINE. 2020. 7 ():- DOI: 10.3389/fmed.2020.00264
IF: 3,9 Q: 1
Lozano RC, Fernandez FJM, Lopez CAD, Tordera EMT, Valiente JC, Delgado FJB. A combined robotic approach to a synchronous upper rectal and prostate cancer - a video vignette. COLORECTAL DISEASE. 2020. 22 (12):2338-2339 DOI: 10.1111/codi.15274
IF: 2,769 Q: 2
Cascales-Campos PA, Lopez-Lopez V, Torres-Melero J, Arjona A, Munoz-Casares FC, Barrios P, Morales R, Pereira F, Bretcha-Boix P, Gonzalez-Bayon L, Gonzalez-Moreno S, Gil J. Survival outcomes in patients aged 75 years and over with peritoneal colorectal carcinomatosis after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC): multicenter study of the Spanish Group of Peritoneal Cancer Surgery (GECOP). CLINICAL & TRANSLATIONAL ONCOLOGY. 2020. 22 (1):130-136 DOI: 10.1007/s12094-019-02124-9
IF: 2,737 Q: 3
Arjona-Sanchez A, Cortes-Guiral D, Duran-Martinez M, Villarejo-Campos P, Sanchez-Hidalgo JM, Casado-Adam A, Rodriguez-Ortiz L, Romero-Ruiz A, Rufian-Andujar B, Espinosa-Redondo E, Valenzuela-Molina F, Rufian-Pena S, Briceno-Delgado J. Complete laparoscopic pelvic peritonectomy plus hyperthermic intraperitoneal chemotherapy. TECHNIQUES IN COLOPROCTOLOGY. 2020. 24 (10):1083-1088 DOI: 10.1007/s10151-020-02277-8
IF: 2,721 Q: 2
Arjona-Sanchez A. Hyperthermic intraperitoneal chemotherapy as adjuvant therapy in locally advanced colon cancer. TECHNIQUES IN COLOPROCTOLOGY. 2021. 25 (1):147-148 DOI: 10.1007/s10151-020-02304-8
IF: 2,721 Q: 2
Navarro-Barrios A, Gil-Martinez J, Ramos-Bernardo I, Barrios P, Munoz-Casares C, Torres-Melero J, Pereira F, Manzanedo I, Arjona A, Martinez-Regueira F, Cascales-Campos PA. Intraperitoneal hyperthermic chemotherapy after cytoreduction in patients with peritoneal metastases from endometrial cancer. The next frontier?. SURGICAL ONCOLOGY-OXFORD. 2020. 33 ():19-23 DOI: 10.1016/j.suronc.2019.12.002
IF: 2,521 Q: 2
Garcia CV, Fernandez FJM, Arjona-Sanchez A, Casado-Adam A, Hidalgo JMS, Pena SR, Delgado JB. Systemic inflammatory markers for the detection of infectious complications and safe discharge after cytoreductive surgery and HIPEC. SURGICAL ONCOLOGY-OXFORD. 2020. 34 ():163-167 DOI: 10.1016/j.suronc.2020.04.013
IF: 2,521 Q: 2
Segura-Sampedro JJ, Morales-Soriano R, Arjona-Sanchez A, Cascales-Campos P. Secondary surgical cytoreduction needs to be assessed taking into account surgical technique, completeness of cytoreduction, and extent of disease. WORLD JOURNAL OF SURGICAL ONCOLOGY. 2020. 18 (1):- DOI: 10.1186/s12957-020-01853-4
IF: 1,963 Q: 2
Publicaciones 2019
Arjona-Sanchez A, Rodriguez-Ortiz L, Baratti D, Schneider MA, Gutiérrez-Calvo A, García-Fadrique A, Tuynman JB, Cascales-Campos PA, Martín VC, Morales R, Salti GI, Arteaga X, Pacheco D, Alonso-Gomez J, Yalkin O, Villarejo-Campos P, Sanchez-Hidalgo JM, Casado-Adam A, Cosano-Alvarez A, Rufian-Peña S, Briceño J. RAS Mutation Decreases Overall Survival After Optimal Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy of Colorectal Peritoneal Metastasis: A Modification Proposal of the Peritoneal Surface Disease Severity Score. Ann Surg Oncol. 2019 Aug;26(8):2595-2604. PMID 31111351
IF: 3.857 D: 1
Sánchez-Hidalgo JM, Rodríguez-Ortiz J, Arjona-Sánchez Á, Rufián-Peña S, Casado-Adam Á, Cosano-Álvarez A, Briceño-Delgado J. Colorectal Peritoneal Metastases: Optimal Management Review. World J Gastroenterol. 2019 Jul 21;25(27):3484-3502. PMID: 31367152
IF: 3.411 Q: 2
Arjona-Sanchez A, Esquivel J, Glehen O, Passot G, Turaga KK, Labow D, Rufian-Peña S, Morales R, van der Speeten K. A minimally invasive approach for peritonectomy procedures and hyperthermic intraperitoneal chemotherapy (HIPEC) in limited peritoneal carcinomatosis: The American Society of Peritoneal Surface Malignancies (ASPSM) multi-institution analysis. Surg Endosc. 2019 Mar;33(3):854-860. PMID 30003349
IF: 2.374 Q: 1
Arjona-Sanchez Á, Rodriguez Ortiz L. ASO Author Reflections: Tending Towards a Personalized Medicine for Colorectal Carcinomatosis by Adding the RAS Mutation Status in the Workup for CRS and HIPEC. Ann Surg Oncol. 2019 Aug;26-8, pp.2605-2606. PMID: 31004296
IF: 3.681 Q: 1
Arjona-Sánchez Á, Durán M, Sánchez-Hidalgo JM, Rufian-Peña S. Peritoneal Carcinomatosis From Ovarian Carcinoma Treated by Interval Laparoscopic Complete Cytoreduction and HIPEC With Extraction Through Natural Orifice. Surg Oncol. 2019 Dec;31:14-15. PMID: 31472328
IF: 3.0 Q: 1
Romero-Ruiz A, Avendaño MS, Dominguez F, Lozoya T, Molina-Abril H, Sangiao-Alvarellos S, Gurrea M, Lara-Chica M, Fernandez-Sanchez M, Torres E, Perdices-López C, Abbara A, Steffani L, Calzado MA, Dhillo WS, Pellicer A,Tena-Sempere M. Deregulation of miR-324/Kiss1/kisspeptin in early ectopic pregnancy: Mechanistic findings with clinical and diagnostic implication. American Journal of Obstetrics and Gynecology. 2019. Vol 220 (5), pp. 480e1 - 480e17. PMID: 30707968
IF: 6.1 D: 1
Romero-Ruiz A, Skorupskaite K, Gaytan F, Torres-Jimenez E, Perdices-Lopez C, Mannaerts BM, Qi S, Leon S, Manfredi-Lozano M, Lopez-Rodriguez C, Avendaño MS, Sanchez-Garrido MA, Vazquez MJ, Pinilla L, van Duin M, Kohout T, Anderson RA, Tena-Sempere, M. Kisspeptin Treatment Induces Gonadotropic Responses and Rescues Ovulation in Preclinical Models & Women with Polycystic Ovary Syndrome. Human Reproduction. 2019 Dec 1;34(12):2495-2512. PMID: 31820802
IF: 5.5 D: 1
Manzanedo I, Pereira F, Rihuete Caro C, Pérez-Viejo E, Serrano Á, Gutiérrez Calvo A, Regueira FM, Casado-Adam Á, Cascales-Campos PA, Arteaga X, García-Fadrique A, Gómez Sanz R, López García A, Zozaya G, Arjona Á, Gil Martínez J. Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Gastric Cancer With Peritoneal Carcinomatosis: Multicenter Study of Spanish Group of Peritoneal Oncologic Surgery (GECOP). Ann Surg Oncol. 2019 Aug;26(8):2615-2621. PMID: 31115852
IF: 3.681 Q: 1
Velasco I, León S, Barroso A, Ruiz-Pino F, Heras V, Torres E, León M, Ruohonen ST, García-Galiano D, Romero-Ruiz A, Sánchez-Garrido MA, Olhsson C, Castellano JM, Roa J, Poutanen M, Pinilla L, Vázquez MJ, Tena-Sempere M. Gonadal Hormone-Dependent vs. -Independent Effects of Kisspeptin Signaling in the Control of Body Weight and Metabolic Homeostasis. Metabolism. Jun 18. pii: S0026-0495(19)30116-7. 2019. ISSN 0026-0495. PMID: 31226351
IF: 6.5 D:1
